App-Quantinova.ai

A patient with seizures and adrenal failure as systemic manifestations of miliary tuberculosis: A case report

Davina Jugnarain - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Addison's disease

Levetiracetam

Bone quality is associated with perinatal nutritional manipulation in adult Wistar rats offspring

Areti Augoulea - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Medical treatment leading to remission of ectopic cushing’s syndrome

Desiree Seguna - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Renal cell carcinoma

Hydrocortisone

Fibrodysplasia ossificans progressiva: Cobbling together a treatment plan for a patient with osteomyelitis

Abilash Sathyanarayanan - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Fibrodysplasia ossificans progressiva

N/A

Prenatal programming of hepatic lipid metabolism: Sex, hormones and lifelong health

Katarzyna Siemienowicz - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Digibind

The utility of pre-test cortisol and other parameters in the prediction of short Synacthen test failure

Ravikumar Ravindran - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Tetracosactide

Liraglutide downregulates the expression of miRNA-424 in patients with obesity

Georgios K Dimitriadis - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

Liraglutide

An atypical presentation of a typical aetiology

Ashutosh Kapoor - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary hyperparathyroidism

Alkaline phosphatase

‘I would say this is a good clinic for friends & family to be looked after in if they need similar treatment or care’ – Young Adult Endocrine (YAE) Service Evaluation

Chona Feliciano - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Phenotypic differences between patients with familial pituitary neuroendocrine tumours due to MEN1 or AIP mutations

Pedro Marques - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Pituitary adenomas

N/A

Polycystic ovary syndrome is burdened with a high comorbidity rate and medication use independent of BMI: A longitudinal community based study

Linda Kujanp - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Polycystic Ovary Syndrome

N/A

From visual disturbance to thyroid cancer: An unexpected journey

Florence Barker - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Papillary carcinoma

Hydrocortisone

Neuromyelitis optica presenting as intractable hiccoughs and SIADH: A Case Report

Sulmaaz Qamar - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Syndrome of inappropriate secretion of antidiuretic hormone

Mycophenolate mofetil

Challenging hypoglycaemia management in a patient with metastatic insulinoma

Angeliki Giannopoulou - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Secondary liver cancer

Octreotide

Medications used by individuals with fibrodysplasia ossificans progressiva (FOP): Data from a global natural history study

Edward C. Hsiao - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Fibrodysplasia ossificans progressiva

N/A

Baseline characteristics from the observational paradighm registry of patients with chronic hypoparathyroidism

Bart L Clarke - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Hypoparathyroidism

rhPTH

Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalised with COVID-19 are associated with greater disease severity

Su Tee - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

The utility of salivary cortisol and cortisone measurement in the assessment of cortisol secretion in adrenal incidentalomas

Basil Issa - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Adrenal carcinoma

Dexamethasone

The impact of variations in laboratory measurements of IGF-1 and random growth hormone on the classification of acromegaly disease activity status: Lessons from the UK Acromegaly Register Reference Laboratory

Bilal Bashir - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Acromegaly

hGH

Efficacy and safety of statin use in children and adolescents with familial hypercholesterolaemia: A systematic review and meta–analysis of randomized–controlled trials

Panagiotis Anagnostis - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypercholesterolemia, Familial, 1

N/A

Filters

45280 Abstracts